NCT01406431View on ClinicalTrials.gov

Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

August 31, 2011

Study Completion Date

October 31, 2012

Conditions

HyperlipidemiaHypertension

Interventions

DRUG

Pitavastatin, Valsartan

Pitavastatin 4mg(2 tablets), Valsartan 160mg(1 tablet)

DRUG

Livalo® fixed combination drug

Livalo® fixed combination drug(1 tablet)

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

Sponsors

Lead Sponsor

JW Pharmaceutical

All Listed Sponsors

lead

JW Pharmaceutical

INDUSTRY